Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910960 · ClinicalTrials.gov registry record · NA
Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02910960 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 50 participants.
The verdict
NCT02910960, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a randomized prospective clinical study comparing the Acquire Biopsy Device to SharkCore Biopsy Device.
Interventions
- DEVICE Acquire EUS Biopsy Device
- DEVICE SharkCore Biopsy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02910960
The ClinicalTrials.gov registry entry for NCT02910960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acquire EUS Biopsy Device is the first listed.
NCT02910960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02910960 about?
NCT02910960 is a clinical study titled "Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses". This is a randomized prospective clinical study comparing the Acquire Biopsy Device to SharkCore Biopsy Device.
What is the current status of trial NCT02910960?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-12. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02910960?
The interventions under investigation include: Acquire EUS Biopsy Device (DEVICE), SharkCore Biopsy System (DEVICE).
Who is sponsoring clinical trial NCT02910960?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.